James Bowen, MD
Swedish Neuroscience Institute
Seattle, WA


Stephen Krieger, MD
Corinne Goldsmith Dickinson Center for MS
New York, NY

David Mattson, MD, PhD
Indiana University Medical Center
Indianapolis, IN

Bruce Cohen, MD
Feinberg School of Medicine
Northwestern University
Chicago, IL

Clyde Markowitz, MD
Hospital of the University of Pennsylvania
Philadelphia, PA

Additional Planning Committee Members

• Mindi Daiga, MBA, The Academy for Continued Healthcare Learning
• Jennifer Hernandez, MBA, The Academy for Continued Healthcare Learning
• Natalie Gallagher, PeerView Institute for Medical Education
• Lisa Keckich, MA, The Academy for Continued Healthcare Learning
• Kirk Tacka, PhD, PeerView Institute for Medical Education
• Helen Tselentis, MEd, The Academy for Continued Healthcare Learning

DISCLOSURE

Current guidelines require that participants in CME/CE activities be made aware of all affiliations or financial interests that may be perceived as influencing the content of an educational activity. The Academy for Continued Healthcare Learning ensures that all faculty and staff involved in the planning, development, and implementation of this activity disclose all potential conflicts of interest and resolve them before the CME/CE activity occurs. Disclosures are provided below:

Aaron Miller, MD, (Chair) Type of financial relationship(s):
Grants and Research Support: Acorda, Biogen Idec, Genenetech, Genzyme, Novartis, Sanofi-Aventis, and Teva
Consultant/Speakers Bureau: Acorda, Avanir, Biogen Idec, BioMarin, Chelsea Therapeutics, Daiichi Sankyo, EMD Serono, GlaxoSmithKline, La-Ser, Merck Serono, Novartis, Nuron Biotech, Ono Pharmaceutical Group, Pfizer, Sanofi-Aventis, and Teva

James Bowen, MD (Faculty) Type of financial relationship(s):
Grants and Research Support: Acorda, Biogen-Idec, BioMS, Celgene, DioGenix, EMD Serono, Genzyme, Novartis, Sanofi-Aventis, and UCB, Inc.
Consultant/Speakers Bureau: Acorda, Berlex, Biogen Idec, Novartis, Pfizer, Serono, and Teva
Stockholder: Amgen
Honorarium Recipient: Acorda, Berlex, Biogen Idec, Novartis, Pfizer, Serono, and Teva

Bruce Cohen, MD (Faculty) Type of financial relationship(s):
Grants and Research Support: Biogen Idec, EMD Serono, Novartis, and Teva Neuroscience (through Northwestern University)
Consultant/Speakers Bureau: Acorda, Bayer, Biogen Idec, CVS-Caremark, EMD Serono, Genzyme, Novartis, and Teva Neuroscience
Stockholder: Abbott Laboratories, CVS-Caremark (common stock)

Stephen Krieger, MD (Faculty) Type of financial relationship(s):
Grants and Research Support: Bayer
Consultant/Speakers Bureau: Bayer, Biogen Idec, EMD Serono, Novartis, and Teva
Honorarium Recipient: Bayer, Biogen Idec, EMD Serono, Novartis, and Teva
Editorial Board: Genzyme

Clyde Markowitz, MD (Faculty) Type of financial relationship(s):
Grants and Research Support: Bayer, Biogen Idec, EMD Serono, Novartis, Ono Pharmaceutical Group, and Teva
Consultant/Speakers Bureau: Acorda, Bayer, Biogen Idec, EMD Serono, Novartis, and Sanofi-Aventis
Advisory Board: Acorda and Bayer

David Mattson, MD, PhD (Faculty) Type of financial relationship(s):
Grants and Research Support: Actelion, Acorda, Bayer, Biogen Idec, Lilly, Genentech, Genzyme, Novartis, Ono Pharmaceutical Group, Sanofi-Aventis, and Teva
Consultant/Speakers Bureau: Acorda, Bayer,Biogen Idec, EMD Serono, Lilly, Novartis, Pfizer, and Teva
Honorarium Recipient: Biogen-Idec, EMD Serono, Novartis, and Teva

Purdue, PVI and ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.